| 标题 |
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of The American Academy of Dermatology 作者:Brett King; Maryanne M. Senna; Natasha Atanaskova Mesinkovska; Charles Lynde; Matthew Zirwas; et al 出版日期:2024-07-23 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)